US Stock MarketDetailed Quotes
DSNKY Daiichi Sankyo (ADR)
- 28.780
- -0.280-0.96%
15min DelayClose Nov 22 16:00 ET
- 28.780
- 0.0000.00%
Post 16:14 ET
54.42BMarket Cap33.98P/E (TTM)
28.840High28.700Low98.97KVolume28.780Open29.060Pre Close2.85MTurnover0.01%Turnover Ratio42.51P/E (Static)1.89BShares42.48052wk High5.17P/B54.42BFloat Cap26.47052wk Low0.20Dividend TTM1.89BShs Float42.480Historical High0.69%Div YieldTTM0.48%Amplitude18.050Historical Low28.773Avg Price1Lot Size
About Daiichi Sankyo (ADR) Company
Daiichi Sankyo Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceuticals. Its products include drugs for the field of oncology such as Trastuzumab deruxtecan, Anti-HER3-ADC, Quizartinib, Milademetan, Valemetostat, Pexidartinib, Edoxaban, Prasugel, and Microgabalin. The company was founded on September 28, 2005 and is headquartered in Tokyo, Japan.
Company Profile
SymbolDSNKY
Company NameDaiichi Sankyo (ADR)
Founded2005
CEOMr. Sunao Manabe
MarketPink Market
Employees14887
Fiscal Year Ends03-31
AddressDaiichi Sankyo Head Office Bldg, A&B,3-5-1 Nihonbashi-honcho,Chuo-Ku
CityTokyo
ProvinceTokyo
CountryJapan
Zip Code103-8426
Phone81-3-6225-1111
Company Executives
- Name
- Position
- Salary
- Sunao Manabe
- Executive Chairman of the Board and Chief Executive Officer
- --
- Takashi Matsumoto
- Director, Managing Executive Officer, Chief Human Resources Officer and Head of Global HR
- --
- Hiroyuki Okuzawa
- Director, President and Chief Operating Officer
- --
- Takashi Fukuoka
- Director, Senior Executive Officer and Head, Global Corporate Strategy
- --
- Shoji Hirashima
- Director, Senior Executive Officer and Head, Japan Business Unit
- --
- Kazuaki Kama
- Chairman of the Board
- --
- Sawako Nohara
- Independent Director
- --
- Yasuhiro Komatsu
- Independent Director
- --
- Takaaki Nishii
- Independent Director
- --
- Yo Honma
- Independent Director
- --
Analysis
Price Target
No Data
Business Data
Revenue by product
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
